Actively Recruiting
REgistry of Pulmonary Arterial Hypertension Associated With CONNECTIVE Tissue Diseases (RECONNECTIVE)
Led by Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran · Updated on 2023-06-29
170
Participants Needed
1
Research Sites
258 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The RECONNECTIVE Registry is an observational single center study, focused on the subgroup of precapillary pulmonary hypertension related to connective tissue diseases. All patients will have hemodynamic confirmation by right heart catheterization and will be follow-up for at least 5 years from admission. All patients diagnosed with Group I Pulmonary Arterial Hypertension (PAH) associated with Connective Tissue Diseases (CTD) and Group IV Pulmonary Hypertension (PH) with CTD will be included. The purpose of the registry is to learn and understand the clinical outcomes and natural history of the pulmonary arterial hypertension in this subgroup of patients to improve the medical care and treatment.
CONDITIONS
Official Title
REgistry of Pulmonary Arterial Hypertension Associated With CONNECTIVE Tissue Diseases (RECONNECTIVE)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients diagnosed with Group I pulmonary arterial hypertension associated with connective tissue diseases
- Patients diagnosed with Group IV pulmonary arterial hypertension with connective tissue diseases and chronic thromboembolic pulmonary disease confirmed by ventilation/perfusion scan or CT pulmonary angiogram
- Patients who have received at least three months of anticoagulation therapy if diagnosed with chronic thromboembolic pulmonary disease
- Patients diagnosed with connective tissue disease based on American College of Rheumatology criteria
- Precapillary pulmonary hypertension confirmed by right heart catheterization with mean pulmonary arterial pressure over 20 mm Hg, pulmonary arterial wedge pressure 15 mm Hg or less, and pulmonary vascular resistance 2.0 Wood units or higher
You will not qualify if you...
- Patients who meet criteria for pulmonary hypertension Groups II, III, or V
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán
Mexico City, Mexico, 14080
Actively Recruiting
Research Team
J
Jose Luis Hernandez Oropeza, PhD
CONTACT
J
Jose de Jesus Rodriguez Andoney, M.Sc.
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here